Analystreport

Orchard Therapeutics plc (NASDAQ: ORTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $9.00 price target on the stock.

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report